Literature DB >> 9378405

Hepatoblastoma and APC gene mutation in familial adenomatous polyposis.

F Cetta, G Montalto, M Petracci.   

Abstract

Entities:  

Mesh:

Year:  1997        PMID: 9378405      PMCID: PMC1891478          DOI: 10.1136/gut.41.3.417

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  6 in total

Review 1.  [Current status of diagnosis and treatment of hepatoblastoma].

Authors:  Purificación García-Miguel; Manuel López Santamaría
Journal:  Clin Transl Oncol       Date:  2005-08       Impact factor: 3.405

2.  Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p.

Authors:  S C Abraham; T T Wu; D S Klimstra; L S Finn; J H Lee; C J Yeo; J L Cameron; R H Hruban
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

3.  The relationships between phenotypic expression in patients with familial adenomatous polyposis (FAP) and the site of mutations in the adenomatous polyposis coli (APC) gene.

Authors:  F Cetta; M Gori; C Baldi; N Raffaelli; M Zuckermann; G Montalto
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

Review 4.  Genetics and clinicopathological findings in thyroid carcinomas associated with familial adenomatous polyposis.

Authors:  F Cetta; M R Pelizzo; M C Curia; A Barbarisi
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 5.  Extra-intestinal manifestations of familial adenomatous polyposis.

Authors:  Emma J Groen; Annemieke Roos; Friso L Muntinghe; Roelien H Enting; Jakob de Vries; Jan H Kleibeuker; Max J H Witjes; Thera P Links; André P van Beek
Journal:  Ann Surg Oncol       Date:  2008-07-09       Impact factor: 5.344

Review 6.  Hepatoblastoma in molecularly defined, congenital diseases.

Authors:  Gunther Nussbaumer; Martin Benesch
Journal:  Am J Med Genet A       Date:  2022-04-28       Impact factor: 2.578

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.